Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Dec;10(6):918–920. doi: 10.1128/aac.10.6.918

Comparative In Vitro Studies of Cinoxacin, Nalidixic Acid, and Oxolinic Acid

Ralph C Gordon a,1, Lynne I Stevens a, Charles E Edmiston Jr a, Kanwal Mohan a
PMCID: PMC429866  PMID: 12717

Abstract

Cinoxacin and nalidixic acid were found to be similar in in vitro activity against 138 Shigella isolates and somewhat less active than oxolinic acid on a weight basis. Cross-resistance developed when 10 shigellae were transferred on increasing amounts of the respective agent contained in Mueller-Hinton agar. Plate dilution studies of the effect of changes in agar pH on the minimum inhibitory concentration revealed that the antibacterial activity increased with decreasing pH. Protein binding investigations revealed a high degree of binding, with nalidixic acid > oxolinic acid > cinoxacin.

Full text

PDF
918

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas E., Clark H., Silverblatt F., Turck M. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Ann Intern Med. 1969 Apr;70(4):713–721. doi: 10.7326/0003-4819-70-4-713. [DOI] [PubMed] [Google Scholar]
  2. Byers P. A., Dupont H. L., Goldschmidt M. C. Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974. Antimicrob Agents Chemother. 1976 Feb;9(2):288–291. doi: 10.1128/aac.9.2.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Giamarellou H., Jackson G. G. Antibacterial activity of cinoxacin in vitro. Antimicrob Agents Chemother. 1975 May;7(5):688–692. doi: 10.1128/aac.7.5.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gordon R. C., Regamey C., Kirby W. M. Serum protein binding of erythromycin, lincomycin, and clindamycin. J Pharm Sci. 1973 Jul;62(7):1074–1077. doi: 10.1002/jps.2600620704. [DOI] [PubMed] [Google Scholar]
  5. Gordon R. C., Thompson T. R., Carlson W., Dyke J. W., Stevens L. I. Antimicrobial resistance of Shigellae isolated in Michigan. JAMA. 1975 Mar 17;231(11):1159–1161. [PubMed] [Google Scholar]
  6. Kurtz S., Turck M. In vitro activity of cinoxacin, an organic acid antibacterial. Antimicrob Agents Chemother. 1975 Mar;7(3):370–373. doi: 10.1128/aac.7.3.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lumish R. M., Norden C. W. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid. Antimicrob Agents Chemother. 1975 Feb;7(2):159–163. doi: 10.1128/aac.7.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Simon H. J., Yin E. J. Microbioassay of antimicrobial agents. Appl Microbiol. 1970 Apr;19(4):573–579. doi: 10.1128/am.19.4.573-579.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wick W. E., Preston D. A., White W. A., Gordee R. S. Compound 64716, a new synthetic antibacterial agent. Antimicrob Agents Chemother. 1973 Oct;4(4):415–420. doi: 10.1128/aac.4.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES